Active Ingredient: DAPSONE
Proprietary Name: DAPSONE
Dosage Form; Route of Administration: GEL; TOPICAL
Strength: 7.5%
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A214722
Product Number: 001
Approval Date: Feb 10, 2022
Applicant Holder Full Name: TORRENT PHARMACEUTICALS LTD
Marketing Status:
Prescription
Patent and Exclusivity Information